In recent years, accumulating studies have described a significant upregulation of COX-2 in NEC rats [13–15,33], indirectly suggesting that the inhibition of COX-2 could be a potential target for the treatment and prevention of NEC. This evidence concerns the gene PTGS2 and necrotizing enterocolitis.